Global Myomectomy Market to Reach USD 1,430.7 Mn by 2035 Amid Rising Demand for Uterus-Preserving Treatments

The global myomectomy market is poised for robust expansion as rising awareness of uterine fibroids and the increasing preference for uterus-sparing procedures continue to reshape women's healthcare. According to the latest industry analysis, the myomectomy market-valued at US$ 642.1 Mn in 2024-is projected to grow at a 7.5% CAGR between 2025 and 2035, reaching US$ 1,430.7 Mn by 2035.

This growth is supported by technological advancements in minimally invasive surgery, greater diagnostic efficiency, and a shift toward fertility-preserving therapeutic options among women worldwide.

Myomectomy, a surgical procedure that removes uterine fibroids while preserving the uterus, has become a preferred treatment choice for women seeking to maintain reproductive potential and avoid hysterectomy. As fibroids remain one of the most common gynecological conditions-affecting nearly 70-80% of women by age 50-the need for effective, uterus-sparing interventions continues to grow dramatically.

The expanding patient pool, especially in the 30-50 age group, combined with advancements in imaging and surgical technologies, has strengthened the commercial prospects of the global myomectomy industry.

Explore the highlights and essential data from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86660

Key Drivers of Market Growth

1. Rising Prevalence of Uterine Fibroids
Uterine fibroids are highly prevalent worldwide, especially among women aged 30-50. According to U.S. Office on Women's Health data, up to 80% of African-American women develop fibroids by age 50-double the incidence observed in white women.
Growing awareness of fibroid-related complications such as heavy menstrual bleeding, pelvic pain, and infertility is prompting more women to seek early diagnosis and surgical intervention.

2. Growing Preference for Uterus-Preserving Procedures
Women's increasing desire to retain fertility-even into their late 30s and 40s-is fueling the demand for myomectomy over hysterectomy.
A 2021 study published in The Journal of Minimally Invasive Gynecology found that 60% of women aged 25-40 preferred myomectomy due to fertility considerations and body image concerns.

3. Advancements in Minimally Invasive Surgical Techniques
Newer solutions such as:
• Robotic-assisted laparoscopic myomectomy
• Advanced ultrasound-guided systems
• Energy-based devices such as harmonic scalpels and vessel sealers
...are transforming the treatment landscape by reducing recovery time, minimizing blood loss, and improving surgical precision.

4. Rising Healthcare Spending and Diagnostic Improvements
Greater access to MRI, transvaginal ultrasound, and routine gynecological check-ups is driving earlier detection of fibroids and enabling timely intervention.

Latest Market Trends

The myomectomy market is experiencing several emerging trends:

1. Surge in Robotic-Assisted Surgery
The FDA's 2024 clearance of Intuitive Surgical's da Vinci 5 system marks a major milestone in robotic gynecologic surgery. Robot-assisted myomectomy offers higher precision and shorter recovery time, especially in difficult-to-reach fibroid locations.

2. Integration of AI and Imaging Enhancements
Enhanced imaging clarity, AI-powered preoperative planning, and navigational guidance tools are enabling greater accuracy in fibroid mapping.

3. Shift Toward Outpatient and Ambulatory Surgical Centers (ASCs)
ASCs are increasingly equipped to offer laparoscopic and hysteroscopic myomectomies, reducing patient burden and hospital costs.

4. Non-Invasive and Incisionless Treatment Innovations
INSIGHTEC and Gynesonics are pioneering techniques such as:
• MR-guided focused ultrasound (MRgFUS)
• Radiofrequency ablation technology
These alternative therapies are gaining acceptance for patients unsuitable for surgery.

Key Players and Industry Leaders

Leading companies shaping the myomectomy market include:
• Medtronic
• Stryker Corporation
• CONMED Corporation
• INSIGHTEC
• CooperSurgical Inc.
• Hologic, Inc.
• Intuitive Surgical
• Karl Storz
• B. Braun Melsungen AG
• Richard Wolf Medical Instruments
• Olympus Corporation
• Minerva Surgical Inc.
• Gynesonics

These market leaders focus on expanding product portfolios, enhancing surgical technology, and training surgeons on advanced techniques to sustain competitive advantage.

Buy this Premium Research Report to gain valuable industry intelligence - https://www.transparencymarketresearch.com/checkout.php?rep_id=86660<ype=S

Recent Developments

Gynesonics Launches SMART OS 2.4 (2024)
In September 2024, Gynesonics unveiled its SMART OS 2.4 software upgrade for the Sonata System, enhancing graphical ultrasound overlays for more precise, incisionless fibroid ablation.

Intuitive Surgical's da Vinci 5 Gains FDA Clearance (2024)
In March 2024, Intuitive Surgical received FDA 510(k) approval for its fifth-generation robotic system, elevating global standards in minimally invasive surgery-an important milestone for advanced myomectomy applications.

Market New Opportunities and Challenges

Opportunities

• Expanding demand in emerging economies due to rising healthcare accessibility
• Growing adoption of robotic and laparoscopic systems
• Technological advancements such as real-time ultrasound mapping and AI-guided surgical planning
• Surge in medical tourism for affordable fibroid treatment in India, Thailand, and Mexico

Challenges
• High cost of robotic and laparoscopic systems limits adoption in low- and middle-income countries
• Limited surgeon expertise in advanced minimally invasive myomectomy techniques
• Post-surgical complications and recurrence risks in complex fibroid cases
• Unequal access to gynecological care in developing regions

Future Outlook

The future of the global myomectomy market is defined by rapid technological innovation, increasing patient awareness, and a growing focus on fertility preservation. While open myomectomy will remain dominant in complex and high-volume cases, robotic and laparoscopic techniques are expected to witness the fastest growth due to improved safety and efficiency.

North America will continue leading the market through 2035, driven by:
• High prevalence of fibroids
• Technological readiness
• Strong reimbursement frameworks
• Presence of top-tier surgical training centers
Meanwhile, Asia Pacific is projected to experience the highest CAGR due to population growth, expanding healthcare infrastructure, and rising urbanization.

Market Segmentation

By Type
• Open Myomectomy
• Laparoscopic Myomectomy
• Hysteroscopic Myomectomy
• Robotic Laparoscopic Myomectomy

By Product
• Laparoscopic Power Morcellators
• Harmonic Scalpel
• Laparoscopic Vessel Sealer
• Hysteroscopic Resectoscope
• Myomectomy Forceps
• Myoma Screw Instrument
• Others (Speculum, Retractors, Myoma Knife, etc.)

By End User
• Hospitals & Clinics
• Ambulatory Surgical Centers

By Region
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Why Buy This Report?

This comprehensive myomectomy market analysis offers:
• Deep insights into market dynamics, size, trends, drivers, restraints, and opportunities
• Breakdown by segments, regions, technologies, and product categories
• Competitive landscape with detailed profiles of leading market players
• Forecast data (2025-2035) for strategic planning
• In-depth qualitative and quantitative evaluation
• Access to PDF + Excel formats for easy data integration
• Insights from analysts specializing in surgical devices and women's health

Explore Latest Research Reports by Transparency Market Research:

Elderly and Disabled Assistive Devices Market: https://www.transparencymarketresearch.com/elderly-disabled-assistive-devices.html

Breast Pumps Market: https://www.transparencymarketresearch.com/breast-pumps-market.html

Ostomy Drainage Bags Market: https://www.transparencymarketresearch.com/ostomy-drainage-bags-market.html

Assistive Technologies for Visually Impaired Market: https://www.transparencymarketresearch.com/assistive-technologies-visually-impaired-market.html

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact Us:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

This release was published on openPR.